Skip to main navigation

USA English

Brazil Português

Canada English Français

Japan Japanese

Blog
Patient Resources
Investors & Media
Careers
Contact

Our Purpose
Our Company
Our Medicines
Our Research

Blog
Patient Resources
Investors & Media
Careers
Contact

Press Releases

Year

Jan 06, 2023

Ultragenyx Reports Preliminary 2022 Revenue; Guidance for 2023 Revenue and Cash Usage; Pipeline Updates and 2023 Milestones

Read More

Jan 04, 2023

Ultragenyx to Present at the 41st Annual J.P. Morgan Healthcare Conference

Read More

INVESTORS & MEDIA

Press Releases
Events & Presentations
Corporate Governance
SEC Filings
Stock Information
Analyst Coverage
Investor FAQ
Contact Us

SHAREHOLDER TOOLS

Print
Email Alerts
RSS Feeds

You are about to leave the Ultragenyx website.

Do you want to continue?

Ultragenyx is not responsible for the content or availability of third party sites.

Our Purpose
Our Company
Our Medicines
Our Research
Careers
Investors & Media

Our Other Websites

www.UltraRareAdvocacy.com
www.UltraCareSupport.com

Linkedin
Facebook

©2023 Ultragenyx Pharmaceutical Inc.. All rights reserved.

Privacy Policy
Cookie Policy